Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Inventory Average (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Inventory Average for 11 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Inventory Average rose 62.49% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2025, up 62.49%, and an annual FY2024 reading of $870500.0, down 44.87% over the prior year.
  • Inventory Average was $1.5 million for Q3 2025 at Arcadia Biosciences, up from $1.4 million in the prior quarter.
  • Across five years, Inventory Average topped out at $4.9 million in Q4 2021 and bottomed at $869500.0 in Q4 2024.
  • Average Inventory Average over 5 years is $2.5 million, with a median of $2.5 million recorded in 2023.
  • The sharpest move saw Inventory Average skyrocketed 85.35% in 2022, then plummeted 68.85% in 2024.
  • Year by year, Inventory Average stood at $4.9 million in 2021, then plummeted by 42.68% to $2.8 million in 2022, then crashed by 38.3% to $1.7 million in 2023, then tumbled by 50.23% to $869500.0 in 2024, then soared by 69.41% to $1.5 million in 2025.
  • Business Quant data shows Inventory Average for RKDA at $1.5 million in Q3 2025, $1.4 million in Q2 2025, and $1.1 million in Q1 2025.